Richard Ding
Chief Executive Officer chez Shanghai Pinnacles Medical Technology Co., Ltd.
Postes actifs de Richard Ding
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Shanghai Pinnacles Medical Technology Co., Ltd.
 Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Chief Executive Officer | - | - |
| Chairman | - | - | |
| Founder | 02/09/2020 | - |
Historique de carrière de Richard Ding
Anciens postes connus de Richard Ding
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| COMBIMATRIX CORP | Director/Board Member | 01/03/2012 | 14/09/2014 |
| Independent Dir/Board Member | 01/03/2012 | 14/09/2014 | |
| BIOMÉRIEUX | Corporate Officer/Principal | 01/01/2006 | 01/01/2008 |
| SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD | President | 12/12/2016 | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - | - |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Director/Board Member | 01/09/2008 | - |
| Chief Executive Officer | 01/09/2008 | - |
Formation de Richard Ding
| University of Utah | Masters Business Admin |
| Southern Illinois University | Graduate Degree |
| Fudan University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Chine | 4 |
| France | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 4 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MYRIAD GENETICS, INC. | Health Technology |
| BIOMÉRIEUX | Health Technology |
| SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD | Health Technology |
| Entreprise privées | 3 |
|---|---|
CombiMatrix Corp.
 CombiMatrix Corp. BiotechnologyHealth Technology CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA. | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Health Technology |
- Bourse
- Insiders
- Richard Ding
- Expérience
